LEGAL PROCEEDINGS - Intellectual Property (Details)							1 Months Ended		2 Months Ended	6 Months Ended
	Aug. 09, 2022 defendant	Jul. 21, 2022	Feb. 02, 2022	Aug. 28, 2020	May 01, 2020	Mar. 26, 2020	Apr. 30, 2021	Mar. 31, 2021 defendant	Sep. 30, 2018 defendant	Jun. 30, 2022 lawsuit defendant
Norwich Pharmaceuticals Inc. Litigation
Loss Contingencies [Line Items]
Stay of approval, period						30 months
Perrigo Israel Pharmaceuticals, Ltd. Litigation
Loss Contingencies [Line Items]
Stay of approval, period				30 months
Taro Pharmaceuticals Inc. Litigation | Subsequent Event
Loss Contingencies [Line Items]
Stay of approval, period		30 months
Padagis Litigation
Loss Contingencies [Line Items]
Stay of approval, period					30 months
MSN Laboratories Private Ltd. Litigation
Loss Contingencies [Line Items]
Stay of approval, period							30 months
PreserVision® AREDS Patent Litigation | Bausch + Lomb
Loss Contingencies [Line Items]
Number of defendants								16
PreserVision® AREDS Patent Litigation | Pending Litigation | Bausch + Lomb | Subsequent Event
Loss Contingencies [Line Items]
Number of defendants	2
PreserVision® AREDS Patent Litigation | Settled Litigation | Bausch + Lomb
Loss Contingencies [Line Items]
Number of defendants										12
PreserVision® AREDS Patent Litigation | Default Judgement | Bausch + Lomb
Loss Contingencies [Line Items]
Number of defendants										2
PreserVision® AREDS Patent Litigation | Declaratory Judgement Action Litigation | Bausch + Lomb
Loss Contingencies [Line Items]
Number of defendants										1
Lumify Paragraph I V Proceedings Slayback ANDA Litigation
Loss Contingencies [Line Items]
Stay of approval, period			30 months
Lumify Paragraph I V Proceedings Lupin ANDA Litigation
Loss Contingencies [Line Items]
Stay of approval, period			30 months
Patent Infringement Litigation | Canada
Loss Contingencies [Line Items]
Number of defendants									4
Apotex Inc. Litigation | Canada | Pending Litigation
Loss Contingencies [Line Items]
Number of lawsuits pending | lawsuit										2